As of 2025-07-06, the EV/EBITDA ratio of Astec Lifesciences Ltd (ASTEC.NS) is -39.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASTEC.NS's latest enterprise value is 24,049.84 mil INR. ASTEC.NS's TTM EBITDA according to its financial statements is -605.78 mil INR. Dividing these 2 quantities gives us the above ASTEC.NS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.6x - 10.9x | 8.8x |
| Forward P/E multiples | 5.6x - 7.6x | 6.2x |
| Fair Price | (485.29) - (515.56) | (514.64) |
| Upside | -151.4% - -154.6% | -154.5% |
| Date | EV/EBITDA |
| 2025-06-20 | -33.62 |
| 2025-06-19 | -32.95 |
| 2025-06-18 | -33.84 |
| 2025-06-17 | -33.81 |
| 2025-06-16 | -35.01 |
| 2025-06-13 | -34.53 |
| 2025-06-12 | -35.07 |
| 2025-06-11 | -35.59 |
| 2025-06-10 | -35.40 |
| 2025-06-09 | -35.43 |
| 2025-06-06 | -35.35 |
| 2025-06-05 | -34.46 |
| 2025-06-04 | -32.63 |
| 2025-06-03 | -32.26 |
| 2025-06-02 | -31.58 |
| 2025-05-30 | -30.86 |
| 2025-05-29 | -30.96 |
| 2025-05-28 | -30.86 |
| 2025-05-27 | -31.33 |
| 2025-05-26 | -31.32 |
| 2025-05-23 | -32.41 |
| 2025-05-22 | -31.93 |
| 2025-05-21 | -31.74 |
| 2025-05-20 | -32.13 |
| 2025-05-19 | -32.76 |
| 2025-05-16 | -32.52 |
| 2025-05-15 | -32.65 |
| 2025-05-14 | -31.41 |
| 2025-05-13 | -31.48 |
| 2025-05-12 | -31.12 |
| 2025-05-09 | -30.07 |
| 2025-05-08 | -30.05 |
| 2025-05-07 | -29.87 |
| 2025-05-06 | -30.55 |
| 2025-05-05 | -30.91 |
| 2025-05-02 | -30.83 |
| 2025-04-30 | -31.22 |
| 2025-04-29 | -31.58 |
| 2025-04-28 | -31.87 |
| 2025-04-25 | -31.94 |
| 2025-04-24 | -33.11 |
| 2025-04-23 | -33.93 |
| 2025-04-22 | -33.78 |
| 2025-04-21 | -33.65 |
| 2025-04-17 | -33.06 |
| 2025-04-16 | -33.39 |
| 2025-04-15 | -31.84 |
| 2025-04-11 | -31.96 |
| 2025-04-09 | -31.70 |
| 2025-04-08 | -31.64 |